BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 1310826)

  • 1. Microvascular Flow Imaging of Residual or Recurrent Hepatocellular Carcinoma after Transarterial Chemoembolization: Comparison with Color/Power Doppler Imaging.
    Kang HJ; Lee JM; Jeon SK; Ryu H; Yoo J; Lee JK; Han JK
    Korean J Radiol; 2019 Jul; 20(7):1114-1123. PubMed ID: 31270975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of doppler ultrasonography in evaluation of early therapeutic efficacy after transcatheter arterial embolization in patients with hepatocellular carcinoma.
    Hibi T; Kumada T; Takeshima K; Ito M; Noda T; Goto S; Sugita F; Sassa T; Ichikawa H; Nakano S
    J Med Ultrason (2001); 2002 Jun; 29(2):47. PubMed ID: 27277740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of transcatheter arterial embolization therapy on hepatocellular carcinomas using contrast-enhanced harmonic power Doppler sonography: comparison with CT, power Doppler sonography, and dynamic MRI.
    Shima T; Mizuno M; Otsuji H; Mizuno C; Obata H; Park H; Nakajo S; Okanoue T
    J Med Ultrason (2001); 2005 Sep; 32(3):107-13. PubMed ID: 27277266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study.
    Cho YZ; Park SY; Choi EH; Baik SK; Kwon SO; Kim YJ; Cha SH; Kim MY
    Clin Mol Hepatol; 2015 Jun; 21(2):165-74. PubMed ID: 26157754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Power Doppler sonography: evaluation of hepatocellular carcinoma after treatment with transarterial embolization or percutaneous ethanol injection therapy.
    Koito K; Namieno T; Ichimura T; Hirokawa N; Syonai T; Hareyama M; Katsuramaki T; Hirata K; Nishi M
    AJR Am J Roentgenol; 2000 Feb; 174(2):337-41. PubMed ID: 10658701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Power Doppler sonography assessment of tumor recurrence after chemoembolization therapy for hepatocellular carcinoma.
    Sumi S; Yamashita Y; Mitsuzaki K; Yamamoto H; Urata J; Nishiharu T; Takahashi M
    AJR Am J Roentgenol; 1999 Jan; 172(1):67-71. PubMed ID: 9888742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow characteristics of hepatic tumors at color Doppler sonography: correlation with arteriographic findings.
    Numata K; Tanaka K; Mitsui K; Morimoto M; Inoue S; Yonezawa H
    AJR Am J Roentgenol; 1993 Mar; 160(3):515-21. PubMed ID: 8381573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Color Doppler sonography for evaluating response to transcatheter arterial embolization and percutaneous ethanol injection therapy and for detecting recurrence of hepatocellular carcinoma.
    Shirato K; Numata K; Mitsui K; Kitamura T; Morita K; Saito S; Morimoto M; Kiba T; Okazaki H; Tanaka K; Sekihara H
    J Ultrasound Med; 2000 Dec; 19(12):807-14; quiz 815-6. PubMed ID: 11127004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: correlation with angiographic findings.
    Fujimoto M; Moriyasu F; Nishikawa K; Nada T; Okuma M
    AJR Am J Roentgenol; 1994 Nov; 163(5):1099-104. PubMed ID: 7976882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Color Doppler sonography of hepatocellular carcinoma before and after treatment by transcatheter arterial embolization.
    Tanaka K; Inoue S; Numata K; Takamura Y; Takebayashi S; Ohaki Y; Misugi K
    AJR Am J Roentgenol; 1992 Mar; 158(3):541-6. PubMed ID: 1310826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Enhanced color flow findings in small hepatocellular carcinoma].
    Maruyama H; Matsutani S; Ebara M; Saisho H
    Nihon Rinsho; 1998 Apr; 56(4):967-74. PubMed ID: 9577618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring treatment response with color and power Doppler.
    Lagalla R; Caruso G; Finazzo M
    Eur J Radiol; 1998 May; 27 Suppl 2():S149-56. PubMed ID: 9652515
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.